146 related articles for article (PubMed ID: 12788858)
1. Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors.
Yon L; Guillemot J; Montero-Hadjadje M; Grumolato L; Leprince J; Lefebvre H; Contesse V; Plouin PF; Vaudry H; Anouar Y
J Clin Endocrinol Metab; 2003 Jun; 88(6):2579-85. PubMed ID: 12788858
[TBL] [Abstract][Full Text] [Related]
2. Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.
Guillemot J; Thouënnon E; Guérin M; Vallet-Erdtmann V; Ravni A; Montéro-Hadjadje M; Lefebvre H; Klein M; Muresan M; Seidah NG; Anouar Y; Yon L
J Mol Endocrinol; 2012 Apr; 48(2):115-27. PubMed ID: 22217803
[TBL] [Abstract][Full Text] [Related]
3. Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma.
Guillemot J; Anouar Y; Montero-Hadjadje M; Grouzmann E; Grumolato L; Roshmaninho-Salgado J; Turquier V; Duparc C; Lefebvre H; Plouin PF; Klein M; Muresan M; Chow BK; Vaudry H; Yon L
Int J Cancer; 2006 Apr; 118(8):2003-12. PubMed ID: 16287097
[TBL] [Abstract][Full Text] [Related]
4. Expression and processing of the neuroendocrine protein secretogranin II in benign and malignant pheochromocytomas.
Guillemot J; Barbier L; Thouennon E; Vallet-Erdtmann V; Montero-Hadjadje M; Lefebvre H; Klein M; Muresan M; Plouin PF; Seidah N; Vaudry H; Anouar Y; Yon L
Ann N Y Acad Sci; 2006 Aug; 1073():527-32. PubMed ID: 17102121
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel secretogranin II-derived peptide (SgII(187-252)) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide.
Anouar Y; Desmoucelles C; Yon L; Leprince J; Breault L; Gallo-Payet N; Vaudry H
J Clin Endocrinol Metab; 1998 Aug; 83(8):2944-51. PubMed ID: 9709974
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization and immunocytochemical localization of EM66, a novel peptide derived from secretogranin II, in the rat pituitary and adrenal glands.
Montero-Hadjadje M; Pelletier G; Yon L; Li S; Guillemot J; Magoul R; Tillet Y; Vaudry H; Anouar Y
J Histochem Cytochem; 2003 Aug; 51(8):1083-95. PubMed ID: 12871990
[TBL] [Abstract][Full Text] [Related]
7. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies.
Portela-Gomes GM; Stridsberg M; Grimelius L; Falkmer UG; Falkmer S
APMIS; 2004 Oct; 112(10):663-73. PubMed ID: 15601318
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterisation and immunohistochemical localisation of the secretogranin II-derived peptide EM66 in the hypothalamus of the jerboa (Jaculus orientalis): modulation by food deprivation.
Boutahricht M; Guillemot J; Montero-Hadjadje M; Bellafqih S; El Ouezzani S; Alaoui A; Yon L; Vaudry H; Anouar Y; Magoul R
J Neuroendocrinol; 2005 Jun; 17(6):372-8. PubMed ID: 15929742
[TBL] [Abstract][Full Text] [Related]
9. Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells.
Guillemot J; Aït-Ali D; Turquier V; Montero-Hadjadje M; Fournier A; Vaudry H; Anouar Y; Yon L
Regul Pept; 2006 Nov; 137(1-2):79-88. PubMed ID: 16963134
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel secretogranin II-derived peptide in the adult and fetal human adrenal gland.
Anouar Y; Yon L; Desmoucelles C; Leprince J; Breault L; Gallo-Payet N; Vaudry H
Endocr Res; 1998; 24(3-4):731-6. PubMed ID: 9888568
[TBL] [Abstract][Full Text] [Related]
11. Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma.
Guérin M; Guillemot J; Thouënnon E; Pierre A; El-Yamani FZ; Montero-Hadjadje M; Dubessy C; Magoul R; Lihrmann I; Anouar Y; Yon L
Regul Pept; 2010 Nov; 165(1):21-9. PubMed ID: 20600356
[TBL] [Abstract][Full Text] [Related]
12. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
13. Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival.
Thouënnon E; Pierre A; Tanguy Y; Guillemot J; Manecka DL; Guérin M; Ouafik L; Muresan M; Klein M; Bertherat J; Lefebvre H; Plouin PF; Yon L; Anouar Y
Endocr Relat Cancer; 2010 Sep; 17(3):637-51. PubMed ID: 20483910
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical distribution of the secretogranin II-derived peptide EM66 in the rat hypothalamus: a comparative study with jerboa.
Boutahricht M; Guillemot J; Montero-Hadjadje M; Barakat Y; El Ouezzani S; Alaoui A; Yon L; Vaudry H; Anouar Y; Magoul R
Neurosci Lett; 2007 Mar; 414(3):268-72. PubMed ID: 17240057
[TBL] [Abstract][Full Text] [Related]
15. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
16. Stathmin as a marker for malignancy in pheochromocytomas.
Björklund P; Cupisti K; Fryknäs M; Isaksson A; Willenberg HS; Akerström G; Hellman P; Westin G
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):27-30. PubMed ID: 19449284
[TBL] [Abstract][Full Text] [Related]
17. Differential Expression of Secretogranins II and III in Canine Adrenal Chromaffin Cells and Pheochromocytomas.
Gomi H; Nagumo T; Asano K; Konosu M; Yasui T; Torii S; Hosaka M
J Histochem Cytochem; 2022 May; 70(5):335-356. PubMed ID: 35400231
[TBL] [Abstract][Full Text] [Related]
18. PACAP stimulates the release of the secretogranin II-derived peptide EM66 from chromaffin cells.
Guillemot J; Ait-Ali D; Turquier V; Montero-Hadjadje M; Fournier A; Vaudry H; Anouar Y; Yon L
Ann N Y Acad Sci; 2006 Jul; 1070():309-12. PubMed ID: 16888183
[TBL] [Abstract][Full Text] [Related]
19. Development of novel tools for the diagnosis and prognosis of pheochromocytoma using peptide marker immunoassay and gene expression profiling approaches.
Anouar Y; Yon L; Guillemot J; Thouennon E; Barbier L; Gimenez-Roqueplo AP; Bertherat J; Lefebvre H; Klein M; Muresan M; Grouzmann E; Plouin PF; Vaudry H; Elkahloun AG
Ann N Y Acad Sci; 2006 Aug; 1073():533-40. PubMed ID: 17102122
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas.
Nagura S; Katoh R; Kawaoi A; Kobayashi M; Obara T; Omata K
Mod Pathol; 1999 Dec; 12(12):1107-11. PubMed ID: 10619262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
